{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T11:29:57Z","timestamp":1790422197312,"version":"4.1.0"},"reference-count":16,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","trasci.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transfusion and Apheresis Science"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1016\/j.transci.2010.09.012","type":"journal-article","created":{"date-parts":[[2010,10,10]],"date-time":"2010-10-10T04:26:44Z","timestamp":1286684804000},"page":"265-268","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Are isolated anti-HBc blood donors in high risk group? The detection of HBV DNA in isolated anti-HBc cases with nucleic acid amplification test (NAT) based on transcription-mediated amplification (TMA) and HBV discrimination"],"prefix":"10.1016","volume":"43","author":[{"given":"H\u00fcsn\u00fc","family":"Altunay","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erdogan","family":"Kosan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilhan","family":"Birinci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armagan","family":"Aksoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaan","family":"Kirali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suat","family":"Saribas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustafa","family":"Aslan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pelin","family":"Yuksel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esra","family":"Alan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osman Sadi","family":"Yenen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bekir","family":"Kocazeybek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.transci.2010.09.012_b0005","series-title":"Transfusion medicine","first-page":"361","article-title":"Transfusion transmitted diseases","author":"Mc Cullough","year":"1998"},{"key":"10.1016\/j.transci.2010.09.012_b0010","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1046\/j.1365-2141.1999.01665.x","article-title":"Evidence that anti-HBc but not HBV DNA testing may prevent some HBV transmission by transfusion","volume":"107","author":"Allain","year":"1999","journal-title":"Br J Haematol"},{"key":"10.1016\/j.transci.2010.09.012_b0015","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1002\/jmv.1890360306","article-title":"Significance of isolated anti-HBc seropositivity by ELISA: implications and the role of radioimmunoassay","volume":"36","author":"Lai","year":"1992","journal-title":"J Med Virol"},{"key":"10.1016\/j.transci.2010.09.012_b0020","first-page":"2770","article-title":"Immunization","author":"Orenstein","year":"1995"},{"key":"10.1016\/j.transci.2010.09.012_b0085","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1053\/jhep.2001.29401","article-title":"Chronic hepatitis B","volume":"34","author":"Lok","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.transci.2010.09.012_b0030","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1002\/hep.1840080411","article-title":"Prevalanece of isolated antibody to hepatitis B core antigen in an area endemic for hepatitis B virus infection: implications in hepatitis B vaccination programs","volume":"8","author":"Lok","year":"1988","journal-title":"Hepatology"},{"key":"10.1016\/j.transci.2010.09.012_b0035","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1128\/jcm.29.3.600-604.1991","article-title":"Improvement in the specificity of assays for detection of antibody to hepatitis B core antigen","volume":"29","author":"Weare","year":"1991","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.transci.2010.09.012_b0040","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1002\/jmv.1890440314","article-title":"Detection of hepatitis B virus DNA in the serum of canadian hepatitis B surface antigen negative. Anti-HBc positive individuals, using the polymerase chain reaction","volume":"44","author":"Scully","year":"1994","journal-title":"J Med Virol"},{"key":"10.1016\/j.transci.2010.09.012_b0045","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1001\/archinte.1993.00410190107012","article-title":"Significance of isolated hepatitis B core antibody","volume":"153","author":"Schifman","year":"1993","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.transci.2010.09.012_b0050","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1046\/j.1537-2995.1993.33393174446.x","volume":"33","author":"Douglas","year":"1993","journal-title":"Transfusion"},{"key":"10.1016\/j.transci.2010.09.012_b0055","doi-asserted-by":"crossref","first-page":"151157","DOI":"10.1002\/jmv.1890420210","article-title":"Presence of hepatitis B and C viral genomes in us blood donors as detected by polymerase chain reaction amplification","volume":"42","author":"Liang","year":"1994","journal-title":"J Med Virol"},{"key":"10.1016\/j.transci.2010.09.012_b0060","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1046\/j.1537-2995.2003.00391.x","article-title":"Frequency of HBV DNA detection in US blood donors testing positive for presence of anti-HBc: implications for transfusion and donor screening","volume":"43","author":"Kleinman","year":"2003","journal-title":"Transfusion"},{"key":"10.1016\/j.transci.2010.09.012_b0065","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1046\/j.1537-2995.2003.00512.x","article-title":"Evaluation of serologic screening of blood donors in India reveals a lack of correlation between anti-HBc titer and PCR amplified HBV DNA","volume":"43","author":"Chaudhuri","year":"2003","journal-title":"Transfusion"},{"key":"10.1016\/j.transci.2010.09.012_b0070","first-page":"69","article-title":"Only Anti-Hbc positivity in hepatitis B virus serology and response to HBV vaccination","volume":"2","author":"Ozacar","year":"1995","journal-title":"Viral Hepatit Derg"},{"key":"10.1016\/j.transci.2010.09.012_b0075","unstructured":"Bal SH, Kuma\u015f LT, Heper Y, Tore O. Investigation of the presence of HBV DNA isolated anti-HBc positive cases and their importance in blood banking, II National Blood Centers and Transfusion Congress. November 2007 Antalya Turkey 15\u201319 [In Turkish]."},{"key":"10.1016\/j.transci.2010.09.012_b0080","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1111\/j.1537-2995.2007.01276.x","article-title":"Infectivity of blood components with low hepatitis B virus DNA levels identified in a lookback program","volume":"47","author":"Satake","year":"2007","journal-title":"Transfusion"}],"container-title":["Transfusion and Apheresis Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050210001564?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050210001564?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T08:49:00Z","timestamp":1761468540000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1473050210001564"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12]]},"references-count":16,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["S1473050210001564"],"URL":"https:\/\/doi.org\/10.1016\/j.transci.2010.09.012","relation":{},"ISSN":["1473-0502"],"issn-type":[{"value":"1473-0502","type":"print"}],"subject":[],"published":{"date-parts":[[2010,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Are isolated anti-HBc blood donors in high risk group? The detection of HBV DNA in isolated anti-HBc cases with nucleic acid amplification test (NAT) based on transcription-mediated amplification (TMA) and HBV discrimination","name":"articletitle","label":"Article Title"},{"value":"Transfusion and Apheresis Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transci.2010.09.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}